Email UpdatesWaiver Elimination (MAT Act)
This web page provides frequently asked questions regarding the 2023 Consolidated Appropriations Act, which eliminates the X-waiver (DATA-Waiver) and increases accessibility of medication-assisted treatment (MAT).
Public domain
Tools are available for public use without current copyright or licensing restrictions, primarily published by Federal, State, or local governments.
Updated DEA Registration Certificate after Removal of X-Waiver
This guidance document provides information regarding issuance of updated DEA registration certificates to reflect Congress’s elimination of the X-waiver (DATA-Waiver) in the Consolidated Appropriations Act of 2023, increasing accessibility of medication-assisted treatment (MAT).
DEA Announces Important Change to Registration Requirement
This letter announces details on Congress's elimination of the X-waiver (DATA-Waiver) to increase buprenorphine accessibility in the Consolidated Appropriations Act of 2023, increasing accessibility of medication-assisted treatment (MAT).
Exploring Value-Based Payment for Substance Use Disorder Services in the United States
This report explores the use of Value-Based Payment model and the potential to improve delivery of integrated and coordinated substance use disorder treatment services. This page also includes the webinar slides and recording from the presentation on this report.
TIP 65: Counseling Approaches To Promote Recovery From Problematic Substance Use and Related Issues
This treatment improvement protocol (TIP) provides guidance to counselors, administrators, and supervisors about recovery-oriented services, supports, and care, allowing them to better serve individuals in or seeking recovery from problematic substance use.
Overdose Prevention and Response Toolkit
This toolkit, designed to augment overdose prevention and reversal training, provides guidance on the role of opioid overdose reversal medications, including naloxone and nalmefene, and how to respond to an overdose.
Use of Medication-Assisted Treatment for Opioid Use Disorder in Criminal Justice Settings
This guide focuses on using medication-assisted treatment for opioid use disorder in jails and prisons and during the reentry process when justice-involved persons return to the community.
Has Treatment for Substance Use Disorders Increased?
This brief presents an overview of trends in substance use disorder treatment between 2015 and 2018 using data from two national surveys.
Age Group Differences in Progress toward Reducing Substance Use Disorders, 2015-2018
This brief presents an overview of trends in the prevalence of substance use disorders between 2015 and 2018 across different age groups.
Variation Across States in Loss of Medicaid Coverage Among Pregnant Beneficiaries with Substance Use Disorders
Using a national Medicaid claims database, this brief estimates the number of pregnant beneficiaries with substance use disorder who lost Medicaid coverage 60 days postpartum at the national and state-level.